OmniComm Systems, Inc.
Industry leaders convene to the 5th Annual Innovation Forum demonstrating transformative effect of OmniComm technology
Fort Lauderdale, FL, November 20, 2015 - OmniComm Systems, Inc., (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, recognizes excellence in innovation at OmniComm’s 5th annual Innovation Forum customer summit.
The two-day event provided an opportunity for OmniComm customers to network, share current innovations, best practices and demonstrate the transformative impact of OmniComm’s technology on clinical development and research. Attendance was up by more than 20% year over year; comprising over 39 life science companies and partners.
Attendees heard from over 14 different OmniComm customer and partner speakers, who achieved significant gains in clinical trial productivity, clinic automation, clinical data quality, operational efficiency and compliance. In addition, there were 18 more sessions that included product demonstrations, customer roundtables and panel discussions.
“As OmniComm continues to grow, we see this annual event as critical in ensuring our clients have the right forum to openly collaborate with our product and business leaders about the technology that they need to be successful and competitive,” said Kuno van der Post, SVP of business development at OmniComm. “This year’s increase in attendance was further punctuated by incredible presentations from our customers demonstrating tangible business benefits and outcomes achieved through OmniComm technology and services.”
The Innovation Forum Excellence in Innovation award recognizes life sciences organizations that have designed and implemented significant innovation using OmniComm technology, resulting in improved organizational operational efficiencies, best practices and business outcomes.
2015 Excellence in Innovation Award recipients:
- Seoul National University Hospital for their full suite implementation of TrialOne®. This included a database migration, device interfaces, integration with the hospital’s EMR system and a unique subject text messaging service. As a result of their implementation of TrialOne, SNUH will recognize numerous business benefits including streamlining their operations while executing early phase clinical trials, increased productivity and the ability to deliver a higher quality product to their trial sponsors.
- The team from a leading global biopharmaceutical received the Excellence in Innovation Award for their process that streamlined data transfer amongst their clinical programs using TrialMaster® EDC by incorporating a trial to trial integration involving five separate studies. The enhanced process allowed for specific data from the last visit of four different antecedent studies to be automatically transferred based on certain triggers to the first visit of a long term safety study. This streamlined efforts at many sites which would have been forced to re-enter a significant amount of data when subjects continued to the extension study.
- University Medical Centre Utrecht received the 2015 Excellence in Innovation Award for their innovative use of TrialMaster’s risk-based and centralized monitoring functionality for the EULAST study. Their use of TrialMaster redaction capability was of significant note as it is used to upload patient informed consent forms directly into TrialMaster while protecting patient identifying information.
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,000 clinical trials. For more information, visit www.omnicomm.com.
OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.